This single-center retrospective study evaluated outcomes of ESRD patients undergoing valve surgery based on whether they received either a mechanical or tissue valve. The study spanned the years 2002-2014, and included 64 mechanical and 151 tissue valve replacements. Even after controlling for confounding variables–given the short expected survival in these patients–there is no salutary effect of using a mechanical over a tissue valve.
Comment: Given the morbidity of anticoagulation in, and the shorter lifespan of, ESRD patients, should we be using mechanical valves at all in these patients?
You are here:
Valve Selection in End-Stage Renal Disease: Should It Always Be Biological?
Submitted by: Arie Blitz
Source: Annals of Thoracic Surgery
Keywords:
Author(s): Matthew L. Williams, MD, Joseph E. Bavaria, MD, Michael A. Acker, MD, Nimesh D. Desai, MD, Prashanth Vallabhajosyula, MD, W. Clark Hargrove, MD, Pavan Atluri, MD, Wilson Y. Szeto, MD
